open access

Online first
Letter to the Editor
Published online: 2021-12-01
Get Citation

Hypersensitivity myocarditis and COVID-19 vaccines

Nicholas G Kounis1, Virginia Mplani2, Ioanna Koniari3, Dimitrios Velissaris4
DOI: 10.33963/KP.a2021.0166
·
Pubmed: 34856634
Affiliations
  1. Department of Cardiology, University of Patras Medical School, Patras, Greece
  2. Intensive Care Unit, University of Patras Medical School, Patras, Greece
  3. Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom
  4. Department of Internal Medicine, University of Patras, Patras, Greece

open access

Online first
Letter to the Editor
Published online: 2021-12-01

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Hypersensitivity myocarditis and COVID-19 vaccines

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Letter to the Editor

Published online

2021-12-01

DOI

10.33963/KP.a2021.0166

Pubmed

34856634

Authors

Nicholas G Kounis
Virginia Mplani
Ioanna Koniari
Dimitrios Velissaris

References (5)
  1. Sokolska JM, Kurcz J, Kosmala W. Every rose has its thorns — acute myocarditis following COVID-19 vaccination. Kardiol Pol. 2021; 79(10): 1153–1154.
  2. Witberg G, Barda N, Hoss S, et al. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med. 2021 [Epub ahead of print].
  3. Almpanis GC, Mazarakis A, Dimopoulos DA, et al. The conundrum of hypersensitivity cardiac disease: hypersensitivity myocarditis, acute hypersensitivity coronary syndrome (Kounis syndrome) or both? Int J Cardiol. 2011; 148(2): 237–240.
  4. Warren CM, Snow TT, Lee AS, et al. Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA Netw Open. 2021; 4(9): e2125524.
  5. Maggio ET. Alkylsaccharides: circumventing oxidative damage to biotherapeutics caused by polyoxyethylene-based surfactants. Ther Deliv. 2013; 4(5): 567–572.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl